NICE recommends first long-acting injectable for HIV patients

NICE recommends first long-acting injectable for HIV

The National Institute for Health and Care Excellence (NICE) has published a positive Final Appraisal Document (FAD) recommending Vocabria (cabotegravir long-acting injection) in combination with...
NHS strikes new agreements to expand life-saving blood thinning drugs

NHS strikes new agreements to expand life-saving blood thinning drugs

NHS Chief Executive Amanda Pritchard has announced that more than 20,000 strokes and 5,000 deaths could be averted after NHS England struck new agreements...
NICE recommendation for cenobamate as treatment for adult epilepsy.

NICE recommendation for cenobamate as treatment for adult epilepsy

The National Institute for Health and Clinical Excellence (NICE) has issued a Final Appraisal Determination (FAD) for Cenobamate▼ (ONTOZRY®). The published FAD recommends cenobamate as an...
JCVI updates it COVID-19 booster vaccination guidance

JCVI updates its COVID-19 booster vaccination guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has updated its guidance and is now advising that all adults aged 40 to 49 should...
Véronique Walsh

Gilead Sciences appoints Véronique Walsh as General Manager of UK and Ireland operations

Gilead Sciences has announced the appointment of Véronique Walsh as General Manager of its UK and Ireland operations, managing a portfolio of products spanning...
EC approves Valneva deal for COVID-19 vaccine

EC approves Valneva deal for COVID-19 vaccine

The European Commission (EC) has approved an agreement pursuant to which Valneva would supply up to 60 million doses of VLA2001, its inactivated COVID-19...
Mandatory COVID vaccination for all health and social care workers

Mandatory COVID vaccination for all health and social care workers

New measures announced by the Government mean that all health and social care workers, including volunteers who have face to face contact with service...
SMC accepts bimekizumab as treatment for plaque psoriasis

SMC accepts bimekizumab as treatment for plaque psoriasis

The Scottish Medicines Consortium (SMC) has accepted BIMZELX®▼ (bimekizumab) for use by NHS Scotland as a treatment option for adults with moderate to severe...
Pfizer’s COVID-19 antiviral treatment reduces hospitalisation and death risk by 89%

Pfizer’s COVID-19 antiviral treatment reduces hospitalisation and death risk by 89%

Pfizer have announced that its investigational novel COVID-19 oral antiviral candidate PAXLOVID™, significantly reduced hospitalization and death, based on an interim analysis of the...
NICE issues draft recommendation for Forxiga to treat kidney disease

NICE issues draft recommendation for Forxiga to treat kidney disease

The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (dapagliflozin) within its marketing authorisation...

Latest articles

NICE recommends Tagrisso for patients with early-stage lung cancer

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
EC grants marketing authorisation for breast cancer treatment Trodelvy

EC grants marketing authorisation for breast cancer treatment Trodelvy

The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
pharmafield logo - pharma news

A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT

What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
JCVI responds to Omicron variant and updates its guidance

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
NICE recommends Tagrisso for patients with early-stage lung cancer

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
People standing in a lab in front of computer screens containing data to show Overcoming the challenges to making data FAIR in pharma

Sales excellence within a value-based promotional model

Forward thinking brand teams are developing a value-based promotional model to promote products in a way which is perceived as offering real differentiation In 2006,...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription